Sells an integrated system of consumable assays, an automation instrument and software that helps academic and biopharmaceutical researchers study proteins in biological samples.
10-K for FY2025, filed Mar 2, 2026
Customers buy instruments and consumables; payment is typically due within 30 or 60 days after shipment. For data-generation and analysis services, Seer bills when it delivers the report, with payment typically due within 30 or 60 days.
10-K for FY2025, filed Mar 2, 2026The Company generates revenue primarily from sales of products and services. The Company’s product, the Proteograph Product Suite, consists…View ↗
Revenue from product sales is recognized when control of the product is transferred, which is generally upon shipment to the customer.…View ↗
Revenue is recorded net of discounts and sales taxes collected on behalf of governmental authorities. Customers are invoiced generally upon…View ↗
$16.6M
10-K for FY2025, filed Mar 2, 2026
$16.6M ↗
Academic and commercial research laboratories, biopharmaceutical companies and biotechnology companies buy the Proteograph. Seer sells directly in the United States and through both direct sales and distributors outside the United States.
10-K for FY2025, filed Mar 2, 2026
No. It lost $73.6M in FY2025.
10-Q for Q3 FY2026, filed Nov 10, 2026
−$13.7MView ↗
8-K, filed Nov 10, 2026
Seer reported third-quarter revenue of $4.0 million, compared with $3.1 million in the second quarter of 2026, and ended the quarter with…View ↗
8-K, filed Oct 29, 2026
Seer to Remain an Independent Public Company Following Conclusion of Special Committee Review ProcessView ↗
8-K, filed Sep 18, 2026
On September 14, 2026, David Horn resigned as the President, Chief Financial Officer and Treasurer of Seer, Inc. (the “Company”) to pursue…View ↗
Growing. Revenue grew 2.5x in 4 years, from $6.6M in FY2021 to $16.6M in FY2025, about 26% a year.
Updated Proteograph products
The newer report describes an updated assay and automation instrument within the Proteograph suite; the older report describes the suite as consumables, an instrument and software.
10-K for FY2022, filed Mar 6, 2023 10-K for FY2025, filed Mar 2, 2026Our mission is to imagine and pioneer new ways to decode the secrets of the proteome to improve human health. Our first product, the…View ↗
The Proteograph Product Suite is a comprehensive solution consisting of consumable assays, an automation instrument, and data analysis…View ↗
Competes with Agilent Technologies, Bio-Techne, Bruker, Danaher, DiaSorin, Illumina, Thermo Fisher Scientific, Alamar Biosciences, Nautilus Biotechnology, Quanterix, and Quantum-Si
10-K for FY2025, filed Mar 2, 2026Current companies that provide proteomics products include Agilent Technologies, Bio-Techne, Bruker, Danaher, DiaSorin, Illumina and Thermo…View ↗
Loading...